Global In-Vitro-Fertilization Market: Trends and Opportunities (2015-2019)
Scope of the Report
The report titled “Global In-Vitro-Fertilization (IVF) Market: Trends and Opportunities (2015-2019)”, analyzes the potential opportunities and significant trends in the global in- vitro-fertilization market. The market size and forecast in value terms and number of IVF cycles for global IVF market has been provided for the period 2010 to 2019, considering 2014 as the base year. The report provides market share analysis of the global IVF market by regions, treatment costs, players and segments. The market is further segment by drug mechanism and different dosage forms.
The report provides detailed country analysis of the IVF markets of Australia, India and the United States. The market size and forecast both in terms of value and volume is covered in the country analysis segment. Also, the various factors driving growth have been analyzed specific to each country.
The report also profiles key market players such as Vitrolife, Monash IVF and OvaScience on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability, financial overview and recent developments.
Country Coverage
United States
India
Australia
Company Coverage
Monash Group
OvaScience
Vitrolife
Executive Summary
IVF stands for in-vitro-fertilization and refers to artificial fertilization for people that want to have a baby but are having difficulty getting pregnant.
Rising incidences of infertility as a consequence of increasing maternal age as more women are now starting families later in life is leading to a rise in demand for IVF treatment. Furthermore, lifestyle induced disorders such as obesity and smoking are contributing towards high infertility rates. These together are thus driving the in-vitro fertilization market, as women and their families prefer in-vitro fertilization procedure more compared to the other available procedures. The global in-vitro fertilization market is also witnessing lucrative growth with an increase in medical tourism activities in the developing economies such as India, China and Brazil. The major limiting factor of IVF market is the cost involved in the treatment. Another challenge is the low level of awareness in the developing economies.
The US emerged as the highest revenue contributing regional market for IVF in 2013. The growth of this market in the region is attributed to the presence of large population base suffering from infertility. Moreover, the availability of high disposable income with the people of this region is contributing to the growth of the IVF market. Asia Pacific is expected to grow at a highest CAGR over the forecasted period of 2015-2019 because of the presence of unmet medical needs coupled with favorable government initiatives pertaining to the development of healthcare infrastructure in emerging economies such as India, China and Japan. Australia has the highest market value and number of IVF cycles in the Asia-Pacific region. Furthermore, increasing medical tourism and availability of cost effective medical procedures in India are expected to positively reinforce In-Vitro fertilization market.
- 1. Executive Summary
- 2. In-Vitro-Fertilization (IVF): An Introduction
- 2.1 IVF Treatment Procedure
- Table 1: IVF Treatment Procedure
- 2.2 Causes of Infertility
- Table 2: Causes of Infertility; 2013
- 2.4 Risk Related to IVF Treatment
- 2.4.1 Multiple Births
- 2.4.2 Premature Delivery and Low Birth Weight
- 2.4.3 Ovarian Hyperstimulation Syndrome
- 2.4.4 Miscarriage
- 2.4.5 Egg-Retrieval Procedure Complications
- 2.4.6 Ectopic Pregnancy
- 2.4.7 Birth Defects
- 2.4.8 Ovarian Cancer
- 2.4.9 Stress
- 3. In-Vitro-Fertilization (IVF): Global Market Analysis
- Table 3: Global Rate of Natural Conception by Age Group over a Year (%); 2014
- 3.1 Global IVF Market: Actual & Forecast
- Table 4: Global IVF Market by Value; 2012-2014 (US$ Billion)
- Table 5: Global IVF Market by Value; 2015E-2019E (US$ Billion)
- 3.2 Global IVF Market Share: An Analysis
- 3.2.1 Global IVF Market Share by IVF Cycles per Region
- Table 6: Global IVF Market Share by IVF Cycles per Regions; 2013
- 3.2.2 Global IVF Treatment Cost by Regions
- Table 7: Global IVF Treatment Costs by Regions; 2014 (US$)
- 3.2.3 Global Fertility Rates by Regions
- Table 8: Global Fertility Rates by Regions; 2014
- 3.2.4 Global IVF Penetration by Regions
- Table 9: Global IVF Penetration (woman undertaking IVF as % of total births); 2013
- 3.2.5 Global IVF Market by Segments
- Table 10: Global IVF Market by Segments; 2013
- 3.2.6 Global IVF Market by Key Players
- Table 11: Global IVF Market by Key Players; 2013
- 4. Country Analysis: In-Vitro-Fertilization (IVF) Market
- 4.1 Australia IVF Market: An Analysis
- Table 13: Australia Number of IVF Cycles per Women; 2009-2014
- Table 12: Australia Number of Fresh IVF Cycles per Women by Age Group; 2013
- 4.1.1 Australia IVF Market: Actual & Forecast
- By Value
- Table 14: Australia IVF Market Size by Value; 2010-2014 (US$ Million)
- Table 15: Australia IVF Market Size by Value; 2015E-2019E (US$ Million)
- By Number of IVF Cycles
- Table 16: Australia and New Zealand IVF Market Size by Number of IVF Cycles; 2008-2013
- Table 17: Australia & New Zealand IVF Market Size by Number of IVF Cycles; 2014E-2019E
- 4.1.2 Australia IVF Market Drivers
- Reproductive Age of Women
- Table 18: Australia Female Population by Age Group; 2003-2013 (Millions)
- Increasing Penetration (% of women opting for IVF over natural conception)
- Table 19: IVF Penetration in Australia; 2002-2013
- Increasing Social Acceptance & Awareness
- Fertility Rate
- Table 20: Australia Fertility Rates; 2005-2013 (births per women)
- Affordability
- 4.2 India IVF Market: An Analysis
- Table A: India IVF Market Statistics; 2014 & 2020
- 4.2.1 India IVF Market: Actual & Forecast
- By Value
- Table 21: India IVF Market by Value; 2012-2014 (US$ Million)
- Table 22: India IVF Market by Value; 2015E-2019E (US$ Million)
- By Number of IVF Cycles
- Table 23: India IVF Market by No. of IVF Cycles; 2014-2019E (in 000s)
- 4.2.2 India IVF Market Drivers
- Increasing Fertility Tourism
- Declining Fertility Rate
- Table 24: India Fertility Rates; 2010-2014 (births per women)
- Affordability
- 4.3 The US IVF Market: An Analysis
- Table 25: The US Fertility Treatment Costs; 2014 (US$)
- Table 26: Cumulative Success Rate of IVF Procedure in the US; 2014
- 4.3.1 The US IVF Market: Actual and Forecast
- By Value
- Table 27: The US IVF Market by Value; 2010-2014 (US$ Billion)
- Table 28: The US IVF Market by Value; 2015E-2019E (US$ Billion)
- By Number of IVF Procedures
- Table 29: The US IVF Market Size by Number of IVF Procedures; 2002-2014
- (in 000s)
- Table 30: The US IVF Market Size by Number of IVF Procedures; 2014E-2019E (in 000s)
- By Number of Infants Births by Using IVF
- Table 31: The US IVF Market Size by Number of Infants Births by Using IVF; 2002-2014 (in 000s)
- Table 32: The US IVF Market Size by Number of Infants Births by Using IVF; 2015E-2019E (in 000s)
- 4.3.2 The US IVF Market Breakdown
- By Age Group
- Table 33: Number of IVF Cycles in the US by Age Group; 2013
- By Number of Embryos Transferred
- Table 34: Average No. of Embryos Transferred in the US; 2013
- Table 35: Percentage of Transfers Resulting in Live Births in the US; 2013
- 4.3.3 The US IVF Market Drivers
- Birth Rates
- Table 36: The US Birth Rates by Age of Women; 1990-2013 (%)
- Declining Fertility Rates
- Table 37: The US Fertility Rates; 2005-2013
- Table 38: Infertility Rates by Age; 2014
- Increasing Same Sex Married Couples
- Table 39: Same Sex Married Couples in the US; 2008-2013
- Obesity
- Table 40: Growing Prevalence of Obesity among the US Adults; 2012-2030
- Table B: Obesity-Related Fertility Issues
- 4.3.4 The US IVF Industry Landscape and M&A Activity
- Table C: M&A Activity in IVF Industry in the US
- 5. Market Dynamics: In-Vitro-Fertilization (IVF) Market
- 5.1 Growth Drivers
- 5.1.1 Decline in Fertility Rates
- Table 41: Global Fertility Rates; 1960-2015E
- 5.1.2 Delay in Motherhood
- Table 42: Global Birth Rate per 1000 Women; 1950-2013
- Table 43: Decline in Male Fertility with Age
- 5.1.3 Rising Healthcare Expenditure
- Table 44: Global Healthcare Expenditure, 2005-2013 (US$ Trillion)
- Table 45: GDP per Capita, 2003-2013 (US$)
- 5.1.4 IVF Success Rates
- Table 46: Success Rates for IVF Treatments; 2013
- Table 47: The UK Live Birth Rates, 1992-2010
- 5.2 Challenges
- 5.2.1 Physical and Emotional Impact
- 5.2.2 Legal Issues
- 5.2.3 Ethical Issues
- 5.2.4 Clinical Issues
- 5.2.5 Cost of the Treatment
- 5.2.6 Multiple Pregnancies
- 5.3 Market Trends
- 5.3.1 Medical Tourism
- 5.3.2 New Technology Trends
- Robotic Surgery Used in Tubal Reversal
- Transfer of Vitrified Embryos
- Surrogate Alternatives
- 5.3.3 Rise in Same Sex Marriages
- 6. Competitive Landscape: In-Vitro-Fertilization (IVF) Market
- Table D: Comparative Analysis of IVF Industry Players; 2014
- 7. Company Profiles: In-Vitro-Fertilization (IVF) Market
- 7.1 Monash
- 7.1.1 Business Overview
- 7.1.2 Financial Overview
- Table 48: Monash Net Revenue; 2012-2014 (US$ Million)
- Table 49: Monash Net Revenue Breakdown; 2012-2014 (US$ Million)
- Table 50: Number of IVF Cycles vs. Revenue per Cycle; 2012-2016E
- 7.1.3 Business Strategy
- Table 51: Monash Group Number of PGD/PGS Procedures; 2011-2014
- 7.2 Vitrolife
- 7.2.1 Business Overview
- 7.2.2 Financial Overview
- Table 52: Vitrolife Net Revenue; 2010-2014 (US$ Million)
- 7.2.3 Business Strategy
- 7.3 OvaScience
- 7.3.1 Business Overview
- 7.3.2 Financial Overview
- Table 53: OvaScience Net Revenue; 2015-2020E (US$ Million)
- 7.3.3 Business Strategy
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook